ArticleP & T : a peer-reviewed journal for formulary management2017

Cancer Immunotherapy, Part 2: Efficacy, Safety, and Other Clinical Considerations.

C Lee VentolaPubMed ↗Full text ↗

No numbers read from the abstract.